27 Oct, 2026
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech…
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Adam Feuerstein is a senior writer and biotech…
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…
The red-brick nursing home tucked off a busy road in Taunton used to be a rare jewel in a beleaguered industry, polished to a high sheen. Floors gleamed from daily…
For five years, biologist David Sabatini has replayed his downfall from the Massachusetts Institute of Technology in the back of his mind, like a movie on repeat. More often than…

ESMO 2026 news: The presentation everyone’s been waiting for

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout […]

3 mins read

Gilead pays $45 million to settle kickback case filed by Texas AG

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions paid for by the Texas Medicaid […]

3 mins read

Trump administration investigates universities for J-1 visa fraud

This story has been updated. The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas commonly used by postdoctoral researchers, a core part of the nation’s biomedical workforce. Vice President JD Vance announced during a press briefing that Harvard, Yale, Stanford, Brown, the California Institute of Technology, Arizona […]

7 mins read